OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Sepsis is currently defined as life-threatening organ dysfunction caused by a dysregulated host response to infection and is estimated globally to be responsible for 11 million deaths each year. Despite the therapeutic potential of immunomodulatory therapy, there have been very few successful trials of such agents in patients with this clinical syndrome. I will describe recent efforts to better understand the pathophysiology of sepsis and stratify the maladaptive host response into sub phenotypes associated with specific mechanisms, showing how this can reveal potential targets and biomarkers to guide their therapeutic use.
